12月9日港股药品及生物科技行业沽空数据盘点，信达生物、康方生物、药明生物沽空金额位居行业前三

证券之星APP12-09 18:06

证券之星消息，12月9日港交所披露数据显示，当日港股药品及生物科技行业的159只个股中有82只被沽空，总沽空股数为1.37亿股，总沽空金额为26.38亿元（港元），而当日药品及生物科技行业的总成交金额为165.3亿元（港元），沽空比例为15.96%。当日药品及生物科技行业总体跌0.97%。从沽空金额来看，信达生物、康方生物、药明生物沽空金额位居行业前三，分别为3.44亿港元、2.88亿港元、2.3...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2590731276?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-09 18:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2590731276","market":"hk","top_or_hot":-1,"title":"12月9日港股药品及生物科技行业沽空数据盘点，信达生物、康方生物、药明生物沽空金额位居行业前三","media":"证券之星APP","content":"<div>\n<p>证券之星消息，12月9日港交所披露数据显示，当日港股药品及生物科技行业的159只个股中有82只被沽空，总沽空股数为1.37亿股，总沽空金额为26.38亿元（港元），而当日药品及生物科技行业的总成交金额为165.3亿元（港元），沽空比例为15.96%。当日药品及生物科技行业总体跌0.97%。从沽空金额来看，信达生物、康方生物、药明生物沽空金额位居行业前三，分别为3.44亿港元、2.88亿港元、2.3...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209181457a72d2c12&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>12月9日港股药品及生物科技行业沽空数据盘点，信达生物、康方生物、药明生物沽空金额位居行业前三</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n12月9日港股药品及生物科技行业沽空数据盘点，信达生物、康方生物、药明生物沽空金额位居行业前三\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-09 18:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209181457a72d2c12&s=b><strong>证券之星APP</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，12月9日港交所披露数据显示，当日港股药品及生物科技行业的159只个股中有82只被沽空，总沽空股数为1.37亿股，总沽空金额为26.38亿元（港元），而当日药品及生物科技行业的总成交金额为165.3亿元（港元），沽空比例为15.96%。当日药品及生物科技行业总体跌0.97%。从沽空金额来看，信达生物、康方生物、药明生物沽空金额位居行业前三，分别为3.44亿港元、2.88亿港元、2.3...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209181457a72d2c12&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0823426308.USD","symbol_name":"法巴中国股票基金","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209181457a72d2c12&s=b","article_id":"2590731276","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209181457a72d2c12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2590731276","pubTimestamp":1765274777,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"证券之星消息，12月9日港交所披露数据显示，当日港股药品及生物科技行业的159只个股中有82只被沽空，总沽空股数为1.37亿股，总沽空金额为26.38亿元（港元），而当日药品及生物科技行业的总成交金额为165.3亿元（港元），沽空比例为15.96%。当日药品及生物科技行业总体跌0.97%。从沽空金额来看，信达生物、康方生物、药明生物沽空金额位居行业前三，分别为3.44亿港元、2.88亿港元、2.3亿港元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0823426308.USD":"法巴中国股票基金","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","LU0348766576.USD":"ALLIANZ LITTLE DRAGONS \"A\" (USD) INC","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","BK1574":"生物医药B类股","LU0348767384.USD":"ALLIANZLITTLE DRAGONS \"A\" (USD) ACC","LU0417516571.SGD":"Allianz Oriental Income Cl AT Acc SGD","LU0140636845.USD":"施罗德大中华区股票A Acc","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0052750758.USD":"富兰克林中国基金A Acc","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","LU0348827113.USD":"ALLIANZ RCM CHINA \"AT\" ACC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","02269":"药明生物","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","IE00B5MMRT66.SGD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","SG9999002463.SGD":"LionGlobal China Growth SGD","LU1720050803.USD":"安联全方位中国股票基金","LU0181495838.USD":"施罗德新兴亚洲A Acc","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","BK1141":"生命科学工具和服务","01801":"信达生物","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK1576":"医药外包概念","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU2476274308.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (USD) ACC","LU0348783233.USD":"安联东方收入型 CI A Dis美元","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","BK1610":"ETF&股票定投概念","BK1161":"生物科技","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","LU3063872942.SGD":"FULLERTON LUX FUNDS ASIA EQUITIES \"I\" (SGD) ACC","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","09926":"康方生物","LU0561508036.HKD":"ALLIANZ CHINA EQUITY \"A\" (HKD) INC"},"translate_title":"On December 9, the short selling data of the pharmaceutical and biotechnology industries in Hong Kong stocks showed that the short selling amount of Innovent Biologics, Akeso Biologics, and WuXi Biologics ranked among the top three in the industry","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1.5,"09926":1.5,"01801":1.5},"content_text":"证券之星消息，12月9日港交所披露数据显示，当日港股药品及生物科技行业的159只个股中有82只被沽空，总沽空股数为1.37亿股，总沽空金额为26.38亿元（港元），而当日药品及生物科技行业的总成交金额为165.3亿元（港元），沽空比例为15.96%。当日药品及生物科技行业总体跌0.97%。从沽空金额来看，信达生物、康方生物、药明生物沽空金额位居行业前三，分别为3.44亿港元、2.88亿港元、2.3亿港元。从沽空比例来看，翰森制药、石四药集团、欧康维视生物-B沽空比例位居行业前三，分别为42.18%、41.61%、41.05%。从沽空比例偏离度来看，艾美疫苗、绿叶制药、神威药业沽空比例偏离度位居行业前三，分别为164.44%、154.9%、152.75%。沽空与卖空含义相同，即在并不持有股票的前提下，通过借入股票（港交所指定可作卖空的证券）获得筹码进而卖出。一般沽空行为是为了获利，等到价格大跌之后在底部买回股票（空头平仓）并归还所借的股票。沽空比例为当日沽空金额与当日总成交金额的比例。沽空比例偏离度为当日沽空比例相较于近30个交易日平均沽空比例的变动幅度。由于港股人民币柜台交易股票成交金额较小，沽空比例普遍偏高，为了避免干扰，已将人民币柜台交易股票从排行表格中剔除。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590731276","isCrawlerRequest":true}